Boadie W. Dunlop, MD

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia

  • 13Articles
  • 69.2KReads
  • 2005–2025Active
  • 89Collaborators
  • 1.3KCitations

About

Boadie W. Dunlop, MD, is affiliated with the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine in Atlanta, Georgia. Dunlop has contributed 13 articles to Psychiatrist.com between 2005 and 2025, focusing on topics such as depression, anxiety, bipolar disorder, and psychedelics. Frequent collaborators include Mark Hyman Rapaport, Jeffrey J. Rakofsky, Becky Kinkead, Philip T. Ninan, and Sagar V. Parikh.

Publications

JCP
Emory Treatment Resistance Interview for PTSD—Short Version
Original Research

Emory Treatment Resistance Interview for PTSD—Short Version

October 1, 2025

The E-TRIP-S offers a simplified method for assessing treatment resistance among PTSD patients.
, ,
JCP
Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management
Original Research

Artificial Intelligence in Depression – Medication Enhancement (AID-ME): A Cluster Randomized Trial of a Clinical Decision Support System for Personalized Depression Treatment Selection and Management

August 27, 2025

This study provides preliminary evidence that longitudinal use of an AI-enabled clinical decision support system can improve outcomes in MDD.
, , , et al
JCP
Maintenance of Antidepressant Effect After 1 Dose of Psilocybin
Original Research

Maintenance of Antidepressant Effect After 1 Dose of Psilocybin

March 3, 2025

Over 52 weeks, a single administration of 25 mg psilocybin suggested longer maintenance of antidepressant effect than both 1 mg and 10 mg.
, , , et al
JCP
Omega-3 Fatty Acids for MDD With High Inflammation
Original Research

Omega-3 Fatty Acids for MDD With High Inflammation

August 22, 2022

This study investigated whether dosage or inflammation levels affect response to omega-3s in MDD patients.
, , , et al
JCP
Original Research

Utility of Combinatorial Pharmacogenomics in Depression

October 31, 2019

This study sought to ascertain the extent that pharmacogenetic testing can inform treatment decisions among patients with treatment-resistant depression whose medications are subject to gene-drug interactions—read the article to...
, , , et al
JCP
Commentary

Duration of a Major Depressive Episode

August 24, 2016

Read commentary about the duration of a major depressive episode and the New Empirical definition of recovery.
,
JCP
Original Research

Massage Monotherapy Remediates Symptoms of Anxiety

July 27, 2016

Almost half of all people with generalized anxiety disorder seek some type of complementary and alternative therapy. See how massage therapy affected anxiety symptoms in this randomized controlled monotherapy...
, , , et al
JCP
Commentary

Antidepressant Signal Detection in the Clinical Trials Vortex

May 27, 2015

,
JCP
Article

Efficacy and Safety of Desvenlafaxine 50 mg/d in a Randomized, Placebo-Controlled Study of Perimenopausal and Postmenopausal Women With Major Depressive Disorder

October 15, 2013

, , , et al
JCP
Article

Treating Nonspecific Anxiety and Anxiety Disorders in Patients With Bipolar Disorder: A Review

November 16, 2010

,
PCC
Original Research

Combination Treatment With Benzodiazepines and SSRIs for Comorbid Anxiety and Depression: A Review

June 17, 2008

,
PCC
Commentary

Commentary: Counseling via Analogy: Improving Patient Adherence in Major Depressive Disorder

December 15, 2005

,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe